Could National Australia Bank Ltd. (NAB) shares hit $30?

National Australia Bank Ltd. (ASX: NAB) has a lot going for it but it isn't perfect. $30 seems about right.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

National Australia Bank Ltd. (ASX: NAB) shares are worth $30, according to one analyst.

NAB share price

Source: Google Finance
Source: Google Finance

According to Dow Jones Newswires, analysts at investment bank UBS recently slapped NAB shares with a $30 price target, up 9% from their prior target.

The average price target of all analysts surveyed by The Wall Street Journal is $30.42. At today's market price of $30.04, that does not leave a lot of room for new investors to buy.

Should you buy today?

At today's prices, it doesn't appear investors are getting a bargain in NAB. However, if interest rates stay low in 2017 it is likely that investors will continue to eye off NAB shares for its big dividend yield.

Indeed, despite forecasts for a reduction in its dividend payments, the consensus among analysts is that NAB will pay a dividend equivalent to a yield of 6.4% fully franked. That's 9.1% grossed up for those tax effective franking credits. Try getting that at the…err…bank!

Foolish Takeaway

In my opinion, a $30 price target would seem appropriate for NAB shares given its opportunity set. Indeed, it does not appear to be a bargain nor a clear sell at today's levels. The best time to buy bank shares is when property prices are faltering and provisions for bad debts soar higher — we are not there yet.

If you want to unearth bargain investments — that also pay big dividends — you need to look further down the market to the blue chips of tomorrow. Down there you will find companies that fewer analysts follow, that also have a longer runway for growth. 

Motley Fool Contributor Owen Raszkiewicz does not have a financial interest in any company mentioned. Owen welcomes -- and encourages -- your feedback on Google+, LinkedIn or you can follow him on Twitter @OwenRask. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »